PharmAust (ASX:PAA) has announced positive top-line data from its Phase 2 veterinary clinical study of monepantel (MPL) for the treatment of canine B-Cell lymphoma. …
PharmAust says data from canine oncology study supports progression to registration studies
October 9, 2023 Australian Biotech
Latest Video
New Stories
-
'If your doctor prescribes it, it should be covered,' pollster recommends as the key message
October 19, 2026 - - Latest News -
The committee that rarely fronts is called to answer at Senate Estimates
October 19, 2026 - - Latest News -
Cancer physicians now running communication skills workshops on how to discuss private pay
October 19, 2026 - - Latest News -
Global headwinds and new contenders set the agenda for Australia's 'Biggest Week in Biotech'
October 19, 2026 - - Latest News -
Mixed PBAC outcomes for multi-cancer immunotherapy listings
October 19, 2026 - -
Pharmac funding wins backing across New Zealand's political divide
October 19, 2026 - - Latest News -
Tavneos to be withdrawn from Australia as CSL pulls vasculitis treatment
October 16, 2026 - - Latest News